Paper
0
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Authors
Andrew Souers,Joel Leverson
Erwin Boghaert,Scott Ackler,Nathaniel Catron,Jun Chen,Brian Dayton,Hong Ding,Sari Enschede,Wayne Fairbrother,David Huang,S.G. Hymowitz,Sha Jin,Seong Khaw,Peter Kovar,Lloyd Lam,Jackie Lee,Heather Maecker,Kennan Marsh,Kylie Mason,Michael Mitten,Paul Nimmer,Anatol Oleksijew,Chang Park,Cheol‐Min Park,Darren Phillips,Andrew Roberts,Deepak Sampath,John Seymour,Morey Smith,Gerard Sullivan,Stephen Tahir,Chris Tse,Michael Wendt,Xiao Yu,John Xue,Haichao Zhang,Rod Humerickhouse,Saul Rosenberg
+37 authors
,Steven ElmoreJournal
Published
Jan 6, 2013
Show more
Save
Tip0
TipSave